116 related articles for article (PubMed ID: 1735616)
21. In vivo stimulation of H-2Dd expression following RadLV infection of thymocytes: increased transcription and DNA-binding activity to sequences 5' of the Dd gene.
Brown GD; Nobunaga T; Morris DR; Meruelo D
Res Immunol; 1991; 142(5-6):431-40. PubMed ID: 1754716
[TBL] [Abstract][Full Text] [Related]
22. Clonal dominance of RadLV-induced lymphomas.
Avni O; Yefenof E; Kotler M
Leuk Res; 1995 Dec; 19(12):971-6. PubMed ID: 8632667
[TBL] [Abstract][Full Text] [Related]
23. Radiation leukemia virus-induced T-cell lymphomas with common T-cell receptor variable region structure and similar binding specificity for retrovirus.
O'Neill HC
Leukemia; 1991 Nov; 5(11):921-7. PubMed ID: 1961032
[TBL] [Abstract][Full Text] [Related]
24. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice.
Rapoport MJ; Jaramillo A; Zipris D; Lazarus AH; Serreze DV; Leiter EH; Cyopick P; Danska JS; Delovitch TL
J Exp Med; 1993 Jul; 178(1):87-99. PubMed ID: 8315397
[TBL] [Abstract][Full Text] [Related]
25. Preferential expression of a common T cell receptor structure by T cells induced to proliferate in vitro with a murine retrovirus.
O'Neill HC
Cell Immunol; 1991 Aug; 136(1):54-61. PubMed ID: 1647884
[TBL] [Abstract][Full Text] [Related]
26. A role for elevated H-2 antigen expression in resistance to neoplasia caused by radiation-induced leukemia virus. Enhancement of effective tumor surveillance by killer lymphocytes.
Meruelo D
J Exp Med; 1979 Apr; 149(4):898-909. PubMed ID: 219130
[TBL] [Abstract][Full Text] [Related]
27. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. I. Cellular analysis of immunosuppression.
Haran-Ghera N; Ben-Yaakov M; Peled A
J Immunol; 1977 Feb; 118(2):600-6. PubMed ID: 320261
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic intervention in radiation-leukemia-virus-induced murine lymphoma by the biological response modifier polysaccharide K.
Yefenof E; Gafanovitch I; Oron E; Bar M; Klein E
Cancer Immunol Immunother; 1995 Dec; 41(6):389-96. PubMed ID: 8635197
[TBL] [Abstract][Full Text] [Related]
29. Phenotypic characterization of mice of thymus target cells susceptible to productive infection by the radiation leukemia virus.
Boniver J; Declève A; Honsik C; Lieberman M; Kaplan HS
J Natl Cancer Inst; 1981 Nov; 67(5):1139-51. PubMed ID: 6117669
[TBL] [Abstract][Full Text] [Related]
30. In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.
Yefenof E; Meidav A; Kedar E
J Exp Med; 1980 Dec; 152(6):1473-83. PubMed ID: 6256461
[TBL] [Abstract][Full Text] [Related]
31. T-cell differentiative capacity of haematopoietic stem cells immortalized in vitro with radiation leukemia virus.
Ho ES; O'Neill HC
Leukemia; 1993 Aug; 7(8):1281-90. PubMed ID: 8102419
[TBL] [Abstract][Full Text] [Related]
32. Radiation leukemia virus: a marker for the study of intrathymic T cell differentiation.
Boniver J; Delvenne C; Janowski M; Courtoy R; Defresne MP
Thymus; 1989; 14(1-3):109-13. PubMed ID: 2560269
[TBL] [Abstract][Full Text] [Related]
33. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4.
Schnare M; Blum H; Jüttner S; Röllinghoff M; Gessner A
J Immunol; 1998 Oct; 161(7):3484-92. PubMed ID: 9759868
[TBL] [Abstract][Full Text] [Related]
34. Target cells and thymus microenvironment in the pathogenesis of thymic lymphomas in C57BL/Ka mice.
Boniver J; Houben-Defresne MP; Goffinet G; Lenaerts P; Betz EH
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):65-9. PubMed ID: 2981792
[TBL] [Abstract][Full Text] [Related]
35. Effects of marrow grafting on preleukemia cells and thymic nurse cells in C57BL/Ka mice after a leukemogenic split-dose irradiation.
Defresne MP; Greimers R; Lenaerts P; Boniver J
J Natl Cancer Inst; 1986 Nov; 77(5):1079-85. PubMed ID: 3534425
[TBL] [Abstract][Full Text] [Related]
36. Observations on lymphomagenesis and lymphoma in AKR mice. A description of prelymphoma changes in the thymus and phenotypic diversity of lymphomas induced by SL3-3 virus.
Hays EF; Bristol G
Thymus; 1992 Jun; 19(4):219-34. PubMed ID: 1385666
[TBL] [Abstract][Full Text] [Related]
37. Endogenous secretion of IL-4 maintains growth and Thy-1 expression of a transformed B cell clone.
Louie SW; Ramirez LM; Krieg AM; Maliszewski CR; Bishop GA
J Immunol; 1993 Jan; 150(2):399-406. PubMed ID: 8093458
[TBL] [Abstract][Full Text] [Related]
38. The effects of passive antiviral immunotherapy in AKR mice: I. The susceptibility of AKR mice to spontaneous and induced T cell lymphomagenesis.
Haran-Ghera N; Peled A; Wu L; Shortman K; Brightman BK; Fan H
Leukemia; 1995 Jul; 9(7):1199-206. PubMed ID: 7630195
[TBL] [Abstract][Full Text] [Related]
39. Induction of interleukin 2 receptor beta chain expression by self-recognition in the thymus.
Hanke T; Mitnacht R; Boyd R; Hünig T
J Exp Med; 1994 Nov; 180(5):1629-36. PubMed ID: 7964450
[TBL] [Abstract][Full Text] [Related]
40. Immunologic characteristics in relation to high and low leukemogenic activity of radiation leukemia virus variants. II. Analysis of the immune response.
Haran-Ghera N; Rubio N
J Immunol; 1977 Feb; 118(2):607-11. PubMed ID: 839072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
